Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × relugolix × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 29 Prostate Adenocarcinoma 2 Adenocarcinoma 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Endometriosis 1

Interventions

Androgen Antagonists 2 relugolix 1 niraparib 1 Prednisone 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07216248 2025-10-29

OPTIMAS

University of Utah

Phase 2 Recruiting

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡